Long-term outcomes after the percutaneous treatment of drug-eluting stent restenosis

JACC: Cardiovascular Interventions

Volumn 4, Issue 2, 2011, Pages 155-164

  Latib, Azeem ^a,b,e   Mussardo, Marco ^a   Ielasi, Alfonso ^a   Tarsia, Giandomenico ^d   Godino, Cosmo ^a,b   Al Lamee, Rasha ^d   Chieffo, Alaide ^a   Airoldi, Flavio ^c   Carlino, Mauro ^a   Montorfano, Matteo ^a   Colombo, Antonio ^a,b  

^a SAN RAFFAELE HOSPITAL   (Italy)

^b EMO GVM CENTRO CUORE COLUMBUS   (Italy)

^c IRCCS MULTIMEDICA   (Italy)

^d SAN CARLO HOSPITAL   (Italy)

^e UNIVERSITY OF CAPE TOWN   (South Africa)

Author keywords

angioplasty; antiplatelet therapy; drug eluting stent(s); restenosis; stent thrombosis

Indexed keywords

RAPAMYCIN; TACROLIMUS; ZOTAROLIMUS;

ACUTE CORONARY SYNDROME; ADULT; AGED; ANGINA PECTORIS; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY RECANALIZATION; FEMALE; FOLLOW UP; HUMAN; IN-STENT RESTENOSIS; ISCHEMIC HEART DISEASE; MALE; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; RETROSPECTIVE STUDY; TREATMENT OUTCOME;

ACUTE CORONARY SYNDROME; AGED; ANGINA PECTORIS; ANGIOPLASTY, BALLOON, CORONARY; CHI-SQUARE DISTRIBUTION; CORONARY ANGIOGRAPHY; CORONARY RESTENOSIS; DRUG-ELUTING STENTS; FEMALE; HUMANS; ITALY; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; MYOCARDIAL ISCHEMIA; PROPORTIONAL HAZARDS MODELS; PROSTHESIS DESIGN; REGISTRIES; RETROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; SOUTH AFRICA; SURVIVAL ANALYSIS; TIME FACTORS; TREATMENT OUTCOME;

EID: 79951982542     PISSN: 19368798     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jcin.2010.09.027     Document Type: Article

References (21)

1. A. Colombo, and A. Latib [Treatment of drug-eluting stent restenosis with another drug-eluting stent: do not fail the second time Rev Esp Cardiol 61 2008 1120 1122
2. J. Cosgrave, G. Melzi, and S. Corbett Comparable clinical outcomes with paclitaxel- and sirolimus-eluting stents in unrestricted contemporary practice J Am Coll Cardiol 49 2007 2320 2328 (Pubitemid 46900991)
3. J. Mehilli, R.A. Byrne, K. Tiroch ISAR-DESIRE 2 Investigators Randomized trial of paclitaxel- versus sirolimus-eluting stents for treatment of coronary restenosis in sirolimus-eluting stents: the ISAR-DESIRE 2 (Intracoronary Stenting and Angiographic Results: Drug Eluting Stents for In-Stent Restenosis 2) study J Am Coll Cardiol 55 2010 2710 2716
4. J. Cosgrave, G. Melzi, and S. Corbett Repeated drug-eluting stent implantation for drug-eluting stent restenosis: the same or a different stent Am Heart J 153 2007 354 359 (Pubitemid 46328767)
5. R. Byrne, R. Iijima, and J. Mehilli [Treatment of paclitaxel-eluting stent restenosis with sirolimus-eluting stent implantation: angiographic and clinical outcomes] Rev Esp Cardiol 61 2008 1134 1139
6. S.C. Smith Jr., T.E. Feldman, and J.W. Hirshfeld Jr. ACC/AHA/SCAI 2005 Guideline update for percutaneous coronary interventionsummary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/SCAI Writing Committee to Update the 2001 Guidelines for Percutaneous Coronary Intervention) J Am Coll Cardiol 47 2006 216 235 (Pubitemid 43005194)
7. R. Mehran, G. Dangas, and A.S. Abizaid Angiographic patterns of in-stent restenosis: classification and implications for long-term outcome Circulation 100 1999 1872 1878 (Pubitemid 29511140)
8. K. Thygesen, J.S. Alpert, H.D. White Joint ESC/ACCF/AHA/WHT Task Force for the Redefinition of Myocardial Infarction Universal definition of myocardial infarction J Am Coll Cardiol 50 2007 2173 2195 (Pubitemid 350123680)
9. D.E. Cutlip, S. Windecker, R. Mehran Academic Research Consortium Clinical end points in coronary stent trials: a case for standardized definitions Circulation 115 2007 2344 2351 (Pubitemid 46685903)
10. D. Hosmer, and S. Lemeshow Applied Survival Analysis: Regression Modeling of Time to Event Data 1999 John Wiley & Sons New York, NY
11. A. Kastrati, A. Schomig, S. Elezi, H. Schuhlen, M. Wilhelm, and J. Dirschinger Interlesion dependence of the risk for restenosis in patients with coronary stent placement in multiple lesions Circulation 97 1998 2396 2401 (Pubitemid 28278182)
12. J.K. Gronnesby, and O. Borgan A method for checking regression models in survival analysis based on the risk score Lifetime Data Anal 2 1996 315 328 (Pubitemid 126415889)
13. S. May, and D.W. Hosmer A simplified method of calculating an overall goodness-of-fit test for the Cox proportional hazards model Lifetime Data Anal 4 1998 109 120 (Pubitemid 128480552)
14. J. Cosgrave, G. Melzi, and G.G. Biondi-Zoccai Drug-eluting stent restenosis: the pattern predicts the outcome J Am Coll Cardiol 47 2006 2399 2404 (Pubitemid 43866381)
15. S. Garg, K. Smith, and R. Torguson Treatment of drug-eluting stent restenosis with the same versus different drug-eluting stent Catheter Cardiovasc Interv 70 2007 9 14 (Pubitemid 47039112)
16. R. Torguson, M. Sabate, and R. Deible Intravascular brachytherapy versus drug-eluting stents for the treatment of patients with drug-eluting stent restenosis Am J Cardiol 98 2006 1340 1344 (Pubitemid 44666639)
17. G.J. Mishkel, A.L. Moore, S. Markwell, M.C. Shelton, and M.E. Shelton Long-term outcomes after management of restenosis or thrombosis of drug-eluting stents J Am Coll Cardiol 49 2007 181 184 (Pubitemid 46054395)
18. S.S. Lee, M.J. Price, and G.B. Wong Early- and medium-term outcomes after paclitaxel-eluting stent implantation for sirolimus-eluting stent failure Am J Cardiol 98 2006 1345 1348 (Pubitemid 44666642)
19. Y.H. Kim, B.K. Lee, and D.W. Park Comparison with conventional therapies of repeated sirolimus-eluting stent implantation for the treatment of drug-eluting coronary stent restenosis Am J Cardiol 98 2006 1451 1454
20. P.A. Lemos, C.A.G. van Mieghem, and C.A. Arampatzis Postsirolimus-eluting stent restenosis treated with repeat percutaneous intervention: late angiographic and clinical outcomes Circulation 109 2004 2500 2502 (Pubitemid 38720546)
21. M.S. Chen, J.M. John, D.P. Chew, D.S. Lee, S.G. Ellis, and D.L. Bhatt Bare metal stent restenosis is not a benign clinical entity Am Heart J 151 2006 1260 1264 (Pubitemid 43866610)